Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v, 5mL Eye Drops

Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v eye drops combine an antibiotic with a non-steroidal anti-inflammatory medicine. They are used when antibacterial cover and control of ocular inflammatory pain are both needed, including appropriate postoperative care.
Instil into the lower-eyelid pocket, close the eye gently and avoid rubbing the operated or inflamed eye. Leave at least five minutes between different eye drops. Use the surgical course dates when this combination forms part of post-operative care.
Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV. Bromfenac reduces prostaglandin synthesis by inhibiting cyclo-oxygenase, limiting inflammatory pain and swelling.
Stinging, irritation, dryness or temporary blur may occur. Bromfenac can rarely delay corneal healing or cause significant corneal-surface injury.
Tell your eye surgeon about aspirin or NSAID allergy, anticoagulants, bleeding tendency, diabetes, severe dry eye or corneal disease. Increased pain or reduced vision after surgery needs prompt assessment.
Combines local antibacterial cover with control of pain and inflammation through a steroid-free mechanism.
No. Bromfenac is an NSAID, so it differs from combinations containing dexamethasone or prednisolone.
The added anti-inflammatory ingredient is not necessary for every bacterial infection and introduces additional corneal and allergy precautions.
Adding a separate bromfenac drop duplicates the NSAID and can increase corneal irritation or healing problems. Do not add a second bromfenac-containing product to the same eye regimen on your own.
No. A lubricant addresses tear-film problems; an antibiotic–NSAID combination has a different role.
No. The two ingredients have separate jobs: moxifloxacin targets susceptible bacteria, while bromfenac reduces inflammatory pain.
Bromfenac: a non-steroidal ocular anti-inflammatory medicine. Corneal epithelium: the outer cell layer of the cornea. Cyclo-oxygenase: an enzyme involved in prostaglandin formation.; AR: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v قطرات للعين; FR: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v collyre; PT: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v colírio; ES: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v gotas oftálmicas; RU: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v глазные капли; ID: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v tetes mata; VI: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v thuốc nhỏ mắt; MS: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v titis mata; TL: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v patak sa mata; ZH-SG: Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v 滴眼液
International B2B Enquiry
Send a structured B2B enquiry for Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v, 5mL Eye Drops under Eye Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v, 5mL Eye Drops